Conduct interim analysis for early stopping for efficacy in VALOR-CKD
Deadline passed; outcome being checked
- Announced
- 11 Jan 2021
- Due
- 31 Dec 2021
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Interim analysis 1: Anticipated 2H 2021”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- Deadline drift +365 days
- Scope drift +66.7%
- 4 versions
-
Version 1 · original · stated 11 Jan 2021
Deadline 31 Dec 2021 (“2H 2021”) · wording expected
-
Version 2 · stated 25 Feb 2021
Deadline 31 Jul 2022 (“in mid-2022”) · wording expected
“Anticipate the second VALOR-CKD renal outcomes trial interim analysis for early stopping for efficacy in mid-2022 when 250 primary renal endpoint events are expected to have accrued.”
-
Version 3 · stated 2 Mar 2021
Deadline 30 Sep 2021 (“3Q 2021”) · target 150 endpoint events · wording expected
“3Q 2021 Anticipate interim analysis for early stopping for efficacy after accrual of 150 endpoint events in VALOR-CKD”
-
Version 4 · stated 2 Mar 2021
Deadline 31 Dec 2022 (“in 2022”) · target 250 endpoint events · wording expected
“Interim analysis for early stopping for efficacy after accrual of 250 endpoint events in VALOR-CKD anticipated in 2022”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Conduct
- Deliverable
- Interim analysis 1
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Tricida, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C595585-021827 · Corrections policy